iRhythm Holdings, Inc. (IRTC) vs TransMedics Group, Inc. (TMDX)

iRhythm Holdings, Inc. and TransMedics Group, Inc. are both Medical Devices companies. iRhythm Holdings, Inc. is the larger, with a market value of $3.7B against $2.9B — 1.3× the size. iRhythm Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; TransMedics Group, Inc. trades at 19.3×. TransMedics Group, Inc. grew revenue faster over the last twelve months: 25.8% against 25.6%. TransMedics Group, Inc. has the higher net margin (22.7% vs −1.69%) and the higher return on invested capital (5.62% vs −6.32%). Across the 20 metrics below, TransMedics Group, Inc. leads on 16 and iRhythm Holdings, Inc. on 4.

Valuation

Metric IRTC TMDX Medical Devices median
P/E n/m 19.30 22.18
P/S 4.40 4.41 2.70
P/B 19.52 5.69 2.46
Price to free cash flow 93.15 37.31 22.53
EV/EBITDA 2,470.56 28.28 11.78
EV/Sales 4.49 4.99 2.38
Earnings yield (0.39%) 5.18% (8.22%)
Free cash flow yield 1.07% 2.68% (7.80%)

Profitability

Metric IRTC TMDX Medical Devices median
Gross margin 71.45% 58.69% 56.01%
Operating margin (3.01%) 12.21% (15.03%)
Net margin (1.69%) 22.69% (20.40%)
Free cash flow margin 4.72% 11.82% (7.24%)
Return on equity (9.63%) 36.28% (15.32%)
Return on assets (1.36%) 12.88% (19.72%)
Return on invested capital (6.32%) 5.62% (10.33%)

Growth

Metric IRTC TMDX Medical Devices median
Revenue growth (TTM) 25.58% 25.82% 8.80%
EPS growth (last fiscal year) 61.71% 382.18% —
Revenue growth, 5-year CAGR 23.02% 88.21% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IRTC TMDX Medical Devices median
Debt to equity 3.50 1.66 0.07
Current ratio 3.86 6.63 2.50
Net debt to EBITDA (2.12) 0.18 0.49

Dividend

Metric IRTC TMDX Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric IRTC TMDX Medical Devices median
Market cap 3.65b 2.91b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack